GlassScriptPhysician profile
Donald L Spicer
NPI 1588668867
$3,986.55
in general payments reported to CMS, 2019-2025
35 companies · $800 in 2025
The $800 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $250 · 2021: $352 · 2022: $619 · 2023: $702 · 2024: $712 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.35 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $595.21 | 2019-2025 | Erleada |
| Axonics, INC. | $565.40 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $419.97 | 2019-2025 | Ams 700, Axonics, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $371.92 | 2019-2024 | Myrbetriq, Xtandi |
| Procept Biorobotics Corporation | $224.96 | 2023-2025 | Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $218.24 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $166.25 | 2021-2025 | |
| Pfizer INC. | $141.94 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $121.89 | 2019-2022 | |
| Coloplast Corp | $117.89 | 2019-2025 | |
| Intuitive Surgical, INC. | $116.63 | 2019-2025 | |
| C. R. Bard, INC. & Subsidiaries | $113.71 | 2020-2025 | Bard Urinary Drainage Bag |
| Abbvie INC. | $108.22 | 2023-2025 | Botox |
| 180 Medical, INC. | $108.15 | 2023-2024 | |
| Teleflex LLC | $85.47 | 2021-2024 | Urolift |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $66.64 | 2022-2024 | |
| Urovant Sciences INC | $43.83 | 2021-2022 | |
| Ethicon US, LLC | $38.50 | 2021 | |
| Zyla Life Sciences, INC. | $34.59 | 2019 | |
| Photocure INC | $33.25 | 2024 | Cysview |
| Laborie Medical Technologies Corp. | $32.42 | 2022-2024 | Urgent PC Neuromodulation System |
| Abc Home Medical Supply, INC. | $32.27 | 2024-2025 | |
| Valencia Technologies Corporation | $26.88 | 2025 | Ecoin Device Kit |
| Baxter Healthcare | $23.55 | 2019 | |
| Olympus America INC. | $21.08 | 2025 | Tecoflex, Bovie, Soltive |
| Medtronic, INC. | $19.40 | 2022 | |
| Karl Storz Endoscopy-America | $18.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.43 | 2022 | |
| Progenics Pharmaceuticals, INC. | $17.66 | 2023 | Pylarify |
| Ferring Pharmaceuticals INC. | $16.48 | 2019 | |
| Immunitybio, INC. | $15.62 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.41 | 2025 | |
| Merck Sharp & Dohme LLC | $14.20 | 2019 | |
| Medtronic USA, INC. | $14.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Spicer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.